AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca fluMist / Fluenz (influenza vaccine) — Worldwide YoY actual (%) (%)
Form 6-K / 20-F Product Sales Table
Latest, Q2 2026
79.0%
Period ended Jun 30, 2026
Change on a year earlier
–
History
12 quarters
Since Q4 2020
Sources
12
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | FluMist / Fluenz (influenza vaccine) — Worldwide YoY actual (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 79.0% | – | Form 6-K FY2026Q2 Earnings Release ↗ |
| Q4 2025 | Dec 31, 2025 | -6.0% | -13.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| Q3 2025 | Sep 30, 2025 | 21.0% | -13.0 pts | Form 6-K FY2025Q3 Earnings Release ↗ |
| Q4 2024 | Dec 31, 2024 | 7.0% | -13.0 pts | Form 6-K FY2024Q4 Earnings Release ↗ |
| Q3 2024 | Sep 30, 2024 | 34.0% | +6.0 pts | Form 6-K FY2024Q3 Earnings Release ↗ |
| Q4 2023 | Dec 31, 2023 | 20.0% | +55.0 pts | Form 6-K FY2023Q4 Earnings Release ↗ |
| Q3 2023 | Sep 30, 2023 | 28.0% | +47.0 pts | Form 6-K FY2023Q3 Earnings Release ↗ |
| Q4 2022 | Dec 31, 2022 | -35.0% | -34.0 pts | Form 6-K FY2022Q4 Earnings Release ↗ |
| Q3 2022 | Sep 30, 2022 | -19.0% | +18.0 pts | Form 6-K FY2022Q3 Earnings Release ↗ |
| Q4 2021 | Dec 31, 2021 | -1.0% | -93.0 pts | Form 6-K FY2021Q4 Earnings Release ↗ |
| Q3 2021 | Sep 30, 2021 | -37.0% | – | Form 6-K FY2021Q3 Earnings Release ↗ |
| Q4 2020 | Dec 31, 2020 | 92.0% | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca FluMist / Fluenz (influenza vaccine) — Worldwide YoY actual (%) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_flumist_world_act_yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.